BNTC vs LHX · $388.7M cap vs P/E 34, rev $5.88B
Benitec Biopharma Ltd ADR (BNTC) versus L3Harris Technologies Inc (LHX) — a side-by-side from cached financials, not a winner call.
Benitec Biopharma Ltd ADR (BNTC) is a biotechnology company listed on NASDAQ.
L3Harris Technologies Inc (LHX) is a aerospace & defense company listed on US.
Latest reported BNTC revenue for 2026-03-31 was $0. Net income was -$32.7M. BNTC currently screens at market cap $388.7M.
Latest reported LHX revenue for 2026-07-03 was $5.88B. Net income was $600.0M. Revenue was up 2.4% from 2026-04-03 to 2026-07-03. LHX currently screens at market cap $58.72B and trailing P/E 34.3.
BNTC currently screens at market cap $388.7M. LHX currently screens at market cap $58.72B and trailing P/E 34.3.
Not investment advice. Open the BNTC and LHX stock pages for the full models.
Not investment advice.